Loading clinical trials...
Loading clinical trials...
A Multicenter, Open-label, Randomized, Bupivacaine-Controlled Study to Evaluate the Pharmacokinetics and Safety of EXPAREL for Postoperative Analgesia in Subjects Aged 0 to Less Than 6 Years Undergoing Cardiac Surgery
Conditions
Interventions
EXPAREL
bupivacaine
Locations
5
United States
Indiana University Health, Riley Hospital For Children
Indianapolis, Indiana, United States
St. Louis Children's Hospital (SLCH)
St Louis, Missouri, United States
Duke University Health System
Durham, North Carolina, United States
University of Oklahoma (OU) - Medical Center - The Children's Hospital
Oklahoma City, Oklahoma, United States
The University of Texas Health Science Center at Houston (UTHSC-H) - McGovern Medical School
Houston, Texas, United States
Start Date
March 29, 2024
Primary Completion Date
January 1, 2027
Completion Date
January 1, 2027
Last Updated
December 29, 2025
NCT07547774
NCT07060495
NCT07058727
NCT07413055
NCT07134660
NCT06862609
Lead Sponsor
Pacira Pharmaceuticals, Inc
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions